These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 2133014
1. Acute increase in exercise capacity with milrinone: lack of correlation with resting hemodynamic responses. Ribeiro JP, White HD, Hartley LH, Colucci WS. Braz J Med Biol Res; 1990; 23(11):1069-78. PubMed ID: 2133014 [Abstract] [Full Text] [Related]
2. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022 [Abstract] [Full Text] [Related]
3. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS. J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566 [Abstract] [Full Text] [Related]
4. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E. Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774 [Abstract] [Full Text] [Related]
5. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. Ludmer PL, Wright RF, Arnold JM, Ganz P, Braunwald E, Colucci WS. Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664 [Abstract] [Full Text] [Related]
6. [Hemodynamic effects of milrinone on patients with chronic congestive heart failure: a multicenter study. Cooperative Group for Phase II Clinical Trial of Milrinone]. Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):599-602. PubMed ID: 8697925 [Abstract] [Full Text] [Related]
7. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure. Pflugfelder PW, O'Neill BJ, Ogilvie RI, Beanlands DS, Tanser PH, Tihal H, Mizgala HF, Fitchett DH, Kostuk WJ. Can J Cardiol; 1991 Sep; 7(1):5-10. PubMed ID: 2025794 [Abstract] [Full Text] [Related]
8. Exercise responses before and after long-term treatment with oral milrinone in patients with severe heart failure. Ribeiro JP, White HD, Arnold JM, Hartley LH, Colucci WS. Am J Med; 1986 Nov; 81(5):759-64. PubMed ID: 3535490 [Abstract] [Full Text] [Related]
9. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. Baim DS, McDowell AV, Cherniles J, Monrad ES, Parker JA, Edelson J, Braunwald E, Grossman W. N Engl J Med; 1983 Sep 29; 309(13):748-56. PubMed ID: 6888453 [Abstract] [Full Text] [Related]
10. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade. Travill CM, Pugh S, Noble MI. Clin Ther; 1994 Sep 29; 16(5):783-92. PubMed ID: 7859237 [Abstract] [Full Text] [Related]
11. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine. Liang CS, Thomas A, Imai N, Stone CK, Kawashima S, Hood WB. J Cardiovasc Pharmacol; 1987 Nov 29; 10(5):509-16. PubMed ID: 2447398 [Abstract] [Full Text] [Related]
12. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good. Varriale P, Ramaprasad S. Pharmacotherapy; 1997 Nov 29; 17(2):371-4. PubMed ID: 9085331 [Abstract] [Full Text] [Related]
13. Acute effects of milrinone on the electrocardiogram and the cardiac hemodynamics of rats with pressure overload-induced congestive heart failure. Desjardins S, Cauchy MJ. Arch Int Pharmacodyn Ther; 1989 Nov 29; 301():182-99. PubMed ID: 2624514 [Abstract] [Full Text] [Related]
14. Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure. White HD, Ribeiro JP, Hartley LH, Colucci WS. Am J Cardiol; 1985 Jul 01; 56(1):93-8. PubMed ID: 4014048 [Abstract] [Full Text] [Related]
15. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure. Maskin CS, Sinoway L, Chadwick B, Sonnenblick EH, Le Jemtel TH. Circulation; 1983 May 01; 67(5):1065-70. PubMed ID: 6831672 [Abstract] [Full Text] [Related]
16. Acute effects of intravenous milrinone in heart failure. Rettig GF, Schieffer HJ. Eur Heart J; 1989 Aug 01; 10 Suppl C():39-43. PubMed ID: 2680496 [Abstract] [Full Text] [Related]
17. Physiologic assessment of milrinone therapy in severe heart failure patients. Dubois-Randé JL, Duval-Moulin AM, Saal JP, Merlet P, Lellouche D, Deleuze P, Dupouy P, Brun P, Loisance D, Castaigne A. J Cardiovasc Pharmacol; 1991 Jun 01; 17(6):941-8. PubMed ID: 1714019 [Abstract] [Full Text] [Related]
18. Preload-dependent hemodynamic effects of milrinone in moderate heart failure. Remme WJ, van Hoogenhuyze DC, Kruijssen HA, Pieper PG, Bruggeling WA. Cardiology; 1992 Jun 01; 80(2):132-42. PubMed ID: 1611632 [Abstract] [Full Text] [Related]
19. Myocardial and vascular actions of milrinone. Colucci WS. Eur Heart J; 1989 Aug 01; 10 Suppl C():32-8. PubMed ID: 2680495 [Abstract] [Full Text] [Related]
20. Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure. Bregagnollo EA, Fortes AH, Cicogna AC. Arq Bras Cardiol; 1999 Feb 01; 72(2):149-60. PubMed ID: 10488574 [Abstract] [Full Text] [Related] Page: [Next] [New Search]